03 Profile
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Clinician · Diabetes
Deborah Horn
Medical director at the University of Texas Center for Obesity Medicine
press citations on 1 topic since 20 Nov 2025 · last quoted 21 Nov 2025
02 Quoted on · 1 of 29 topics
Deborah Horn: key facts
- Kind of voice
- Clinician
- Role
- Medical director at the University of Texas Center for Obesity Medicine
- Quoted on
- Diabetes
- Tracked press citations
- 3
- Most recently quoted
- 21 Nov 2025
- First quoted
- 20 Nov 2025
04 The signal · where Deborah Horn sits on diabetes
Ranked 48= of 100 voices quoted in the press on diabetes, level with 35 others on 3 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Douglas TwenefourClinicianHead of Clinical, Diabetes UK36 - 2
Dr Elizabeth RobertsonSector leaderDirector of Research and Clinical, Diabetes UK20 - 3=
Helen KnightRegulatorDirector of Medicines Evaluation, National Institute for Health and Care Excellence (NICE)15 - 48=Professor Sarah RichardsonAcademicProfessor at the University of Exeter3
- 48=Dr Francesco ZaccardiClinicianHonorary Consultant in Cardiometabolic Medicine and Associate Professor in Clinical Epidemiology and Health Data Science at the University of Leicester3
- 48=Deborah HornClinicianMedical director at the University of Texas Center for Obesity Medicine3
- 84=
Professor Victoria Tzortziou BrownClinicianChair of Council, Royal College of General Practitioners (RCGP)2 - 84=
Professor Azeem MajeedAcademicProfessor of Primary Care and Public Health and Head of the Department of Primary Care and Public Health, Imperial College London2
Showing the leaders and the ranks around 48=, of 100 voices · See every voice on the topic →
05 On the record · press
What Deborah Horn has said
- technologynetworks.com1
- thesun.co.uk1
- uknip.co.uk1
Where Deborah Horn has been quoted
- 01New Pill Sparks Weight Loss Revolutionuknip.co.uk · 21 Nov 2025
- 02New daily fat jab PILL is 'cheaper, highly effective and has fewer side effects'thesun.co.uk · 20 Nov 2025
- 03Oral GLP-1 Pill Shows Strong Results for Obesity and Diabetestechnologynetworks.com · 20 Nov 2025
Verbatim
“Orforglipron's safety profile and predicted lower cost will open the door for many more people worldwide needing obesity treatment”
“This could open the door to treatment for all.”
“We know it is harder for individuals with diabetes to lose weight. It is exciting to have an oral medication that provides double-digit weight loss, which on average was 23 lbs. Once FDA approved, orforglipron is scheduled to be available in 2026 at a significantly decreased cost compared to current injectables. This could position it to be the 'metformin' of obesity and become widely covered by insurance plans, opening the door to treatment for all”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.